Compare ELTX & ROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTX | ROC |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.3M | 71.2M |
| IPO Year | 2014 | 2025 |
| Metric | ELTX | ROC |
|---|---|---|
| Price | $1.90 | $3.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $13.67 | $7.75 |
| AVG Volume (30 Days) | ★ 258.8K | 25.4K |
| Earning Date | 11-12-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,301,000.00 | ★ $16,979,679.00 |
| Revenue This Year | N/A | $21.30 |
| Revenue Next Year | N/A | $72.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.90 |
| 52 Week Low | $1.44 | $3.35 |
| 52 Week High | $16.00 | $7.80 |
| Indicator | ELTX | ROC |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 41.05 |
| Support Level | $1.74 | N/A |
| Resistance Level | $1.97 | $4.59 |
| Average True Range (ATR) | 0.15 | 0.28 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 79.63 | 38.42 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.